Artelo Biosciences (ARTL) Other financing activities (2020 - 2024)
Artelo Biosciences (ARTL) posted quarterly Other financing activities of $55000.0 for Q1 2024, down 90.37% quarter-over-quarter from $571000.0 in Q4 2021.
Artelo Biosciences (ARTL) Other financing activities (2020 - 2024) Analysis & Trends
Artelo Biosciences (ARTL) has reported Other financing activities for 3 consecutive years, with $55000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Other financing activities changed N/A year-over-year to $55000.0; the TTM figure through Dec 2025 stood at $55000.0 (changed 0.0% YoY), while the FY2025 annual figure was $132000.0, changed N/A from the prior year.
- Other financing activities slipped to $55000.0 in Q1 2024 per ARTL's latest filing, from $571000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $5.3 million in Q1 2021 and bottomed at $41000.0 in Q4 2020.
- Historically, Other financing activities has averaged $1.5 million across 3 years, with a median of $313000.0 in 2021.
- On a YoY basis, Other financing activities climbed as much as 1292.68% in 2021 and fell as far as 1292.68% in 2021.
- Artelo Biosciences' Other financing activities stood at $41000.0 in 2020, then surged by 1292.68% to $571000.0 in 2021, then tumbled by 90.37% to $55000.0 in 2024.
- Business Quant data shows ARTL's Other financing activities at $55000.0 in Q1 2024, $571000.0 in Q4 2021, and $5.3 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 55,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Nov 30, 2021 | 571,000.00 |
| Nov 30, 2021 | 571,000.00 |
| Feb 28, 2021 | 5.29 Mn |
| Feb 28, 2021 | 5.29 Mn |
| Nov 30, 2020 | 41,000.00 |
| Nov 30, 2020 | 41,000.00 |